Stafford Kristin
Insider CIK 1970438 · NVCR Director · ZYME EVP, Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| NVCR NovoCure Ltd | A Award deriv | 2026-06-03 | 2026-06-05 | 16,999 | — | $0 | 16,999 | SEC↗ |
| NVCR NovoCure Ltd | A Award | 2026-06-03 | 2026-06-05 | 11,610 | — | $0 | 22,934 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2026-06-02 | 2026-06-03 | 2,945 | $15.77 | $46.4K | 11,324 | SEC↗ |
| ZYME Zymeworks Inc. | A Award deriv | 2026-04-06 | 2026-04-07 | 50,000 | — | $0 | 50,000 | SEC↗ |
| ZYME Zymeworks Inc. | A Award deriv | 2026-04-06 | 2026-04-07 | 119,000 | — | $0 | 119,000 | SEC↗ |
| ZYME Zymeworks Inc. | A Award deriv | 2026-04-06 | 2026-04-07 | 178,000 | — | $0 | 178,000 | SEC↗ |
| NVCR NovoCure Ltd | A Award deriv | 2025-06-04 | 2025-06-06 | 16,697 | — | $0 | 16,697 | SEC↗ |
| NVCR NovoCure Ltd | A Award | 2025-06-04 | 2025-06-06 | 11,215 | — | $0 | 14,269 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2025-06-03 | 2025-06-04 | 999 | $17.28 | $17.3K | 3,054 | SEC↗ |
| NVCR NovoCure Ltd | A Award deriv | 2024-06-05 | 2024-06-06 | 6,229 | — | $0 | 6,229 | SEC↗ |
| NVCR NovoCure Ltd | A Award | 2024-06-05 | 2024-06-06 | 4,053 | — | $0 | 4,053 | SEC↗ |
| NVCR NovoCure Ltd | A Award deriv | 2023-05-09 | 2023-05-11 | 15,873 | — | $0 | 15,873 | SEC↗ |
| NVCR NovoCure Ltd | A Award deriv | 2023-05-09 | 2023-05-17 | 15,873 | — | $0 | 15,873 | SEC↗ |